Developer docs
API playgroundTry for free, no card

Search company profiles

Harmonic Bionics

Full company profile

uuid0002axr

Namestring
Harmonic Bionics
Legal namestring
Harmonic Bionics, Inc.
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Harmonic Bionics is a commercial-stage rehabilitation robotics company that developed, registered, and commercialized the Harmony SHR, a bilateral upper extremity robotic exoskeleton for neurorehabilitation. The Harmony SHR architecture is differentiated by a shoulder design that replicates the glenohumeral joint and includes a scapular component to facilitate scapulohumeral rhythm, supporting approximately 85% of the shoulder's natural range of motion. The platform integrates Bilateral Sync mode for robotic-assisted mirror therapy, integrated motion and effort sensing for objective joint-angle and force assessment, motorized sizing, weight support for earlier post-stroke intervention, and the proprietary EsmaCAT high-speed mechatronics and software platform released as a separate product. Multiple granted US patents protect the actuators, compliant sensing mechanism, electronic boards, and mechanical exoskeleton architecture, with a registered Harmony SHR trademark.

The company monetizes primarily through capital-equipment sales of the Harmony SHR to enterprise rehabilitation hospitals, clinics, and university research programs, supplemented by professional services for training and ongoing support. Pricing is opaque and quote-based; the company uses consultative field sales backed by customized ROI modeling, live virtual demonstrations, in-person demonstrations at rehab facilities, and a heavy conference presence (APTA CSM, AOTA Inspire, ACRM, AAPM&R, LSI Emerging Medtech Summit). Domestic direct sales are complemented by an international channel-partner network covering Hong Kong and Macau (Healthlink Holdings), Qatar (Intermodal Services Co.), Vietnam (BaoNam Co.), and South Korea (Curexo Inc.). Named reference customers include Barrow Neurological Institute (Dignity Health, the first US clinical installation, two systems), Brooks Rehabilitation, CUHK Medical Centre (the first international installation), St. David's Rehabilitation Hospital, and research placements at the University of Houston REIGN Lab and Auburn University WeBR Lab.

Harmonic Bionics was founded in 2016 in Austin, Texas by Dr. Ashish Deshpande and Dr. Youngmok Yun out of research at the University of Texas at Austin, following NSF I-Corps customer discovery work. The leadership team combines academic founders with commercial executives including CEO Christopher Prentice (ex-Mazor Robotics and Medtronic), CFO Chris White, and CCO/Strategy Officer Gusty Denis. The company raised approximately $13-14M across an NSF SBIR Phase 1 grant ($250K in 2018), a $2.45M early-round in 2020, a $7M Series A led by KNet Investment Partners and Big Basin Capital in May 2021, and a $3M strategic investment from Curexo Inc. in May 2022. FDA registered Harmony SHR as a Class II 510(k)-exempt device in April 2023, achieved first US clinical installation in October 2023, first international installation in May 2024, and was acquired by Bioness Medical on June 18, 2025 to expand Bioness's neuro-rehabilitation portfolio. Bioness Medical itself had been acquired by Accelmed Partners on December 31, 2024.

Short descriptiontext

Harmonic Bionics developed the Harmony SHR, a bilateral upper extremity robotic exoskeleton for neurorehabilitation. It sold capital equipment to rehabilitation hospitals, clinics, and university research programs across the US and select international markets before being acquired by Bioness Medical in June 2025.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersAustin, United States
HQ citystring
Austin
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
rehabilitation robotics, medical exoskeletons, neuro rehabilitation devices, upper extremity therapy, robotic therapy systems
Industry5 codes
PRIMARYHDAAAIAC
Healthcare & Assistive Robotics
SECONDARYHLAHAMAG
Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Rehabilitation & Mobility Aids (DME)
SECONDARYHLAHAEAI
Orthotics & Bracing (Spinal/Lower/Upper Extremity Orthoses)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHSADAIAH
Hand & Upper Extremity Therapy (OT/CHT)
Home & Personal Services/Fitness, Wellness & Personal Training/Physical Therapy, Rehabilitation & Corrective Exercise
SECONDARYHSADAIAM
Corrective Exercise, Movement Screening & Biomechanics
Home & Personal Services/Fitness, Wellness & Personal Training/Physical Therapy, Rehabilitation & Corrective Exercise
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code3 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Rehabilitation Robotics
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Harmony SHR Hardware Sales
TypeHardware Sales
Description

Sale of the Harmony SHR bilateral upper extremity robotic rehabilitation exoskeleton system to rehabilitation hospitals, clinics, and healthcare facilities. Hardware device sold as a capital equipment purchase. Post-sale support and service likely bundled or available as separate professional services.

harmonicbionics.com
2Professional Services (Training & Support)
TypeProfessional Services
Description

Training, in-service demonstrations, and ongoing support services for rehabilitation facilities deploying Harmony SHR. Contact form for customized ROI models for hospitals or facilities.

harmonicbionics.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Pricing details1 tier
1Harmony SHR Robotic Rehabilitation System
ModelOther
Notes

No publicly disclosed pricing. Prospective customers contact the company for pricing, demos, and customized ROI models.

harmonicbionics.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Harmony SHR
Description

A bilateral upper extremity robotic rehabilitation system that works with a patient's scapulohumeral rhythm (SHR) to enable natural, comprehensive arm and shoulder therapy for those living with neurological and musculoskeletal movement impairments.

harmonicbionics.com
Core offering1 text field

Harmonic Bionics develops and sells the Harmony SHR, a bilateral upper extremity robotic rehabilitation exoskeleton used by physical and occupational therapists to treat patients recovering from stroke, spinal cord injury, traumatic brain injury, and other neurological or musculoskeletal movement impairments. The system combines a biomechanically matched shoulder design (mimicking scapulohumeral rhythm) with bilateral sync mirror therapy, motorized sizing, and integrated motion/effort sensors to deliver objective, data-driven therapy. The company also offers EsmaCAT, a standalone high-speed mechatronics and software platform for robotic systems.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Patients achieved 20 degree increase in shoulder abduction range of motion and 10 degree increase in shoulder flexion after less than 4 weeks of Harmony SHR therapy — their largest gains in over a year (patient Bob Kuhn, Brooks Rehabilitation)
+3 more records
Product overview1 text field

Harmonic Bionics is a commercial-stage robotics company offering a focused product portfolio centered on its flagship Harmony SHR bilateral upper extremity robotic rehabilitation system. Harmony SHR works with a patient's scapulohumeral rhythm to enable natural, comprehensive arm and shoulder therapy for those with neurological and musculoskeletal movement impairments. The company also offers the EsmaCAT mechatronics and software platform as a standalone product. The ecosystem includes therapy applications, patient attachments, and assessment capabilities. The company was acquired by Bioness Medical in June 2025 to expand Bioness's neuro rehabilitation portfolio.

Product and service2 records
1Harmony SHR
CategoryRehabilitation Robotics Hardware
Description

Bilateral upper extremity robotic rehabilitation exoskeleton system that works with a patient's scapulohumeral rhythm to enable natural, comprehensive arm and shoulder therapy for patients recovering from stroke, spinal cord injury, traumatic brain injury, and other neurological or musculoskeletal movement impairments. Sold as capital equipment to rehabilitation hospitals, clinics, and research institutions.

2EsmaCAT Mechatronics and Software Platform
CategoryRobotics Platform Software and Hardware
Description

High-speed mechatronics and software platform released as a standalone product, enabling high-speed communication between multiple actuators and a master controller for robotic systems.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
1Healthlink Holdings LTD
Strategic tierPrimaryTypeChannel Partner/ Reseller/ DistributorAnnounced on2022-08-02
Description

Exclusive distributor agreement for Hong Kong and Macau territories. Healthlink Holdings, established in 2008, focuses on innovative medical, rehabilitation and sport science equipment. The company has over 30 years of experience marketing pharmaceutical, medical, and rehabilitation products and represents many world-renowned manufacturers. Sales Director Samuel Chan noted stroke incidence in Hong Kong increased over 50% in the prior ten years.

harmonicbionics.com
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2022-05-27
Description

Strategic partnership with South Korea-based Curexo Inc. includes a $3 million investment and agreement for Harmonic Bionics to assist with US promotion and business development for Curexo’s Morning Walk S200 robotic gait rehabilitation system and CUVIS-spine surgical robot. Curexo listed on Korean Stock Exchange with Morning Walk S200 in use at 23 hospitals in South Korea. The partnership was extended in April 2024 for Curexo to distribute Harmony SHR in South Korea.

Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2020-12-21
Description

Partnership to assist with US distribution of rebless™, an FDA-registered smart rehabilitation device for upper and lower limbs (elbow, wrist, ankle, knee). rebless received a CES 2021 Innovation Award in the Health and Wellness category. Controlled through a smartphone app with telemedicine and clinic management software. H Robotics CEO is Dr. Ig-Mo Koo.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Distributor for Qatar, located at Building 69, Suite 201, B-Ring Road, Doha. Tel: +974 4462 1168.

5BaoNam Co., LTD
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Distributor for Vietnam, located at House No. 12, Lane 198, Thai Ha Street, Trung Liet Ward, Dong Da District, Hanoi City, Vietnam.

harmonicbionics.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Dr. Jinsook Roh’s lab (2022 NSF CAREER award recipient) purchased Harmony SHR for research on neural mechanisms of motor coordination and motor impairment quantification in stroke patients. Provides clinical feedback and research validation.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Tyromotion (Austria) makes the Diego, Pablo, and Amadeo upper-extremity rehabilitation robotic and mechatronic devices. Like Harmonic Bionics, it sells into neurological and orthopedic rehab clinics and competes for the same therapy budget and Class II capital equipment slots.

TypeDirect peer
Description

Myomo makes the MyoPro powered upper-extremity orthosis for stroke and neurological patients. It is a direct competitor in the upper-extremity rehab and assistance category with overlapping clinical use cases (stroke, neurological injury) and similar hospital/patient buyers.

3Hocoma (DIH Medical)
TypeDirect peer
Description

Hocoma, now part of DIH Medical, is the established leader in upper-extremity robotic rehabilitation with the Armeo product family (ArmeoPower, ArmeoSpring, ArmeoSenso). It is the most direct competitor to Harmony SHR globally and shares the same customer base of inpatient and outpatient rehabilitation hospitals.

TypeBroad incumbent
Description

ReWalk Robotics is a publicly listed exoskeleton company focused primarily on lower-extremity personal and rehab devices (ReWalk Personal 6.0). It is a broad incumbent in the medical exoskeleton category and shares the same hospital and rehabilitation buyer universe as Harmonic Bionics.

TypeOthers
Description

Bioness Medical is the strategic acquirer of Harmonic Bionics (June 2025) and now the parent company. It sells the L300 Go (FES) and other neuro-rehab products, so it is now the commercial platform through which Harmony SHR reaches customers, making it both a corporate parent and an adjacent rehab portfolio company.

TypeDirect peer
Description

Fourier Intelligence (China) makes the ArmMotus EMU and similar upper-extremity rehab robots, plus lower-extremity RehabHub devices. It is a direct competitor targeting the same hospital, clinic, and international distributor accounts as Harmonic Bionics.

TypeEmerging player
Description

BioXtreme is a startup developing the BioXtreme upper-extremity robotic rehabilitation system for shoulder and arm therapy in neurological patients. It is an emerging player with partial overlap in product category and target use case (post-stroke upper-limb rehab), although it remains at an earlier commercialization stage.

TypeDirect peer
Description

Saebo is a US-based vendor of upper-extremity rehabilitation devices (SaeboFlex, SaeboReach, SaeboStim). It competes for the same occupational therapy and stroke rehab budgets, although its products are mechanical/electrical orthoses rather than full robotic exoskeletons.

TypeBroad incumbent
Description

Ekso Bionics is a publicly listed wearable exoskeleton company best known for the EksoGT lower-extremity gait rehab device, with broader exposure in industrial and medical robotics. It is a broad incumbent in rehabilitation robotics with overlapping hospital buyers but a different anatomical focus.

TypeEmerging player
Description

Aretech makes the ZeroG bodyweight-support and gait rehab system for neurological and orthopedic rehabilitation. It is an emerging player with partial overlap in the rehab robotics category, sharing the same inpatient rehab hospital buyers but focused on lower-extremity and balance therapy.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors12 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Harmonic Bionics

Rehabilitation Roboticsharmonicbionics.com

Harmonic Bionics developed the Harmony SHR, a bilateral upper extremity robotic exoskeleton for neurorehabilitation. It sold capital equipment to rehabilitation hospitals, clinics, and university research programs across the US and select international markets before being acquired by Bioness Medical in June 2025.

What Harmonic Bionics does

Harmonic Bionics is a commercial-stage rehabilitation robotics company that developed, registered, and commercialized the Harmony SHR, a bilateral upper extremity robotic exoskeleton for neurorehabilitation. The Harmony SHR architecture is differentiated by a shoulder design that replicates the glenohumeral joint and includes a scapular component to facilitate scapulohumeral rhythm, supporting approximately 85% of the shoulder's natural range of motion. The platform integrates Bilateral Sync mode for robotic-assisted mirror therapy, integrated motion and effort sensing for objective joint-angle and force assessment, motorized sizing, weight support for earlier post-stroke intervention, and the proprietary EsmaCAT high-speed mechatronics and software platform released as a separate product. Multiple granted US patents protect the actuators, compliant sensing mechanism, electronic boards, and mechanical exoskeleton architecture, with a registered Harmony SHR trademark.

The company monetizes primarily through capital-equipment sales of the Harmony SHR to enterprise rehabilitation hospitals, clinics, and university research programs, supplemented by professional services for training and ongoing support. Pricing is opaque and quote-based; the company uses consultative field sales backed by customized ROI modeling, live virtual demonstrations, in-person demonstrations at rehab facilities, and a heavy conference presence (APTA CSM, AOTA Inspire, ACRM, AAPM&R, LSI Emerging Medtech Summit). Domestic direct sales are complemented by an international channel-partner network covering Hong Kong and Macau (Healthlink Holdings), Qatar (Intermodal Services Co.), Vietnam (BaoNam Co.), and South Korea (Curexo Inc.). Named reference customers include Barrow Neurological Institute (Dignity Health, the first US clinical installation, two systems), Brooks Rehabilitation, CUHK Medical Centre (the first international installation), St. David's Rehabilitation Hospital, and research placements at the University of Houston REIGN Lab and Auburn University WeBR Lab.

Harmonic Bionics was founded in 2016 in Austin, Texas by Dr. Ashish Deshpande and Dr. Youngmok Yun out of research at the University of Texas at Austin, following NSF I-Corps customer discovery work. The leadership team combines academic founders with commercial executives including CEO Christopher Prentice (ex-Mazor Robotics and Medtronic), CFO Chris White, and CCO/Strategy Officer Gusty Denis. The company raised approximately $13-14M across an NSF SBIR Phase 1 grant ($250K in 2018), a $2.45M early-round in 2020, a $7M Series A led by KNet Investment Partners and Big Basin Capital in May 2021, and a $3M strategic investment from Curexo Inc. in May 2022. FDA registered Harmony SHR as a Class II 510(k)-exempt device in April 2023, achieved first US clinical installation in October 2023, first international installation in May 2024, and was acquired by Bioness Medical on June 18, 2025 to expand Bioness's neuro-rehabilitation portfolio. Bioness Medical itself had been acquired by Accelmed Partners on December 31, 2024.

Harmonic Bionics firmographics

Firmographics
Name
Harmonic Bionics
Legal name
Harmonic Bionics, Inc.
Website
https://harmonicbionics.com
Company type
Private
Founded year
2016
Operating status
Acquired
Headcount range
1–10 employees
Short description
Harmonic Bionics developed the Harmony SHR, a bilateral upper extremity robotic exoskeleton for neurorehabilitation. It sold capital equipment to rehabilitation hospitals, clinics, and university research programs across the US and select international markets before being acquired by Bioness Medical in June 2025.
Ownership category
akta.pro rank

Harmonic Bionics industry classification

Industry
Product category
Rehabilitation Robotics
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHDAAAIAC
Healthcare & Assistive Robotics
SECONDARYHLAHAMAG
Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Rehabilitation & Mobility Aids (DME)
SECONDARYHLAHAEAI
Orthotics & Bracing (Spinal/Lower/Upper Extremity Orthoses)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHSADAIAH
Hand & Upper Extremity Therapy (OT/CHT)
Home & Personal Services/Fitness, Wellness & Personal Training/Physical Therapy, Rehabilitation & Corrective Exercise
SECONDARYHSADAIAM
Corrective Exercise, Movement Screening & Biomechanics
Home & Personal Services/Fitness, Wellness & Personal Training/Physical Therapy, Rehabilitation & Corrective Exercise

Keywords

  • Rehabilitation robotics
  • Medical exoskeletons
  • Neuro rehabilitation devices
  • Upper extremity therapy
  • Robotic therapy systems

Where Harmonic Bionics is headquartered

Location

Headquarters

HQ city
Austin
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Harmonic Bionics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Revenue model

  1. Harmony SHR Hardware Sales: Sale of the Harmony SHR bilateral upper extremity robotic rehabilitation exoskeleton system to rehabilitation hospitals, clinics, and healthcare facilities. Hardware device sold as a capital equipment purchase. Post-sale support and service likely bundled or available as separate professional services.
  2. Professional Services (Training & Support): Training, in-service demonstrations, and ongoing support services for rehabilitation facilities deploying Harmony SHR. Contact form for customized ROI models for hospitals or facilities.

Pricing tiers

ModelBillingPrice
Other—Harmony SHR Robotic Rehabilitation System

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Harmonic Bionics product offering

Product offering

Core offering

Harmonic Bionics develops and sells the Harmony SHR, a bilateral upper extremity robotic rehabilitation exoskeleton used by physical and occupational therapists to treat patients recovering from stroke, spinal cord injury, traumatic brain injury, and other neurological or musculoskeletal movement impairments. The system combines a biomechanically matched shoulder design (mimicking scapulohumeral rhythm) with bilateral sync mirror therapy, motorized sizing, and integrated motion/effort sensors to deliver objective, data-driven therapy. The company also offers EsmaCAT, a standalone high-speed mechatronics and software platform for robotic systems.

Product overview

Harmonic Bionics is a commercial-stage robotics company offering a focused product portfolio centered on its flagship Harmony SHR bilateral upper extremity robotic rehabilitation system. Harmony SHR works with a patient's scapulohumeral rhythm to enable natural, comprehensive arm and shoulder therapy for those with neurological and musculoskeletal movement impairments. The company also offers the EsmaCAT mechatronics and software platform as a standalone product. The ecosystem includes therapy applications, patient attachments, and assessment capabilities. The company was acquired by Bioness Medical in June 2025 to expand Bioness's neuro rehabilitation portfolio.

Differentiator

Problem solved

Functional benefit

Brands

  • Harmony SHR: A bilateral upper extremity robotic rehabilitation system that works with a patient's scapulohumeral rhythm (SHR) to enable natural, comprehensive arm and shoulder therapy for those living with neurological and musculoskeletal movement impairments.

Products and services

  • Harmony SHR Bilateral upper extremity robotic rehabilitation exoskeleton system that works with a patient's scapulohumeral rhythm to enable natural, comprehensive arm and shoulder therapy for patients recovering from stroke, spinal cord injury, traumatic brain injury, and other neurological or musculoskeletal movement impairments. Sold as capital equipment to rehabilitation hospitals, clinics, and research institutions.
  • EsmaCAT Mechatronics and Software Platform High-speed mechatronics and software platform released as a standalone product, enabling high-speed communication between multiple actuators and a master controller for robotic systems.

Quantifiable outcome

  • Patients achieved 20 degree increase in shoulder abduction range of motion and 10 degree increase in shoulder flexion after less than 4 weeks of Harmony SHR therapy — their largest gains in over a year (patient Bob Kuhn, Brooks Rehabilitation)
  • +3 more outcomes

Companies that use Harmonic Bionics

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles2 records

Harmonic Bionics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Harmonic Bionics partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered primary, core and minor.

  • Healthlink Holdings LTDprimaryChannel Partner/ Reseller/ Distributor · 2 August 2022Exclusive distributor agreement for Hong Kong and Macau territories. Healthlink Holdings, established in 2008, focuses on innovative medical, rehabilitation and sport science equipment. The company has over 30 years of experience marketing pharmaceutical, medical, and rehabilitation products and represents many world-renowned manufacturers. Sales Director Samuel Chan noted stroke incidence in Hong Kong increased over 50% in the prior ten years.
  • Curexo Inc.coreChannel Partner/ Reseller/ Distributor · 27 May 2022Strategic partnership with South Korea-based Curexo Inc. includes a $3 million investment and agreement for Harmonic Bionics to assist with US promotion and business development for Curexo’s Morning Walk S200 robotic gait rehabilitation system and CUVIS-spine surgical robot. Curexo listed on Korean Stock Exchange with Morning Walk S200 in use at 23 hospitals in South Korea. The partnership was extended in April 2024 for Curexo to distribute Harmony SHR in South Korea.
  • H Robotics Inc.minorChannel Partner/ Reseller/ Distributor · 21 December 2020Partnership to assist with US distribution of rebless™, an FDA-registered smart rehabilitation device for upper and lower limbs (elbow, wrist, ankle, knee). rebless received a CES 2021 Innovation Award in the Health and Wellness category. Controlled through a smartphone app with telemedicine and clinic management software. H Robotics CEO is Dr. Ig-Mo Koo.
  • Intermodal Services Co. W.L.L.minorChannel Partner/ Reseller/ DistributorDistributor for Qatar, located at Building 69, Suite 201, B-Ring Road, Doha. Tel: +974 4462 1168.
  • BaoNam Co., LTDminorChannel Partner/ Reseller/ DistributorDistributor for Vietnam, located at House No. 12, Lane 198, Thai Ha Street, Trung Liet Ward, Dong Da District, Hanoi City, Vietnam.
  • University of Houston REIGN LabminorStrategic or Co-development PartnerDr. Jinsook Roh’s lab (2022 NSF CAREER award recipient) purchased Harmony SHR for research on neural mechanisms of motor coordination and motor impairment quantification in stroke patients. Provides clinical feedback and research validation.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Harmonic Bionics competitors and assessment

Company assessment

Direct peers

  • Tyromotion: Tyromotion (Austria) makes the Diego, Pablo, and Amadeo upper-extremity rehabilitation robotic and mechatronic devices. Like Harmonic Bionics, it sells into neurological and orthopedic rehab clinics and competes for the same therapy budget and Class II capital equipment slots.
  • Myomo: Myomo makes the MyoPro powered upper-extremity orthosis for stroke and neurological patients. It is a direct competitor in the upper-extremity rehab and assistance category with overlapping clinical use cases (stroke, neurological injury) and similar hospital/patient buyers.
  • Hocoma (DIH Medical): Hocoma, now part of DIH Medical, is the established leader in upper-extremity robotic rehabilitation with the Armeo product family (ArmeoPower, ArmeoSpring, ArmeoSenso). It is the most direct competitor to Harmony SHR globally and shares the same customer base of inpatient and outpatient rehabilitation hospitals.
  • Fourier Intelligence: Fourier Intelligence (China) makes the ArmMotus EMU and similar upper-extremity rehab robots, plus lower-extremity RehabHub devices. It is a direct competitor targeting the same hospital, clinic, and international distributor accounts as Harmonic Bionics.
  • Saebo: Saebo is a US-based vendor of upper-extremity rehabilitation devices (SaeboFlex, SaeboReach, SaeboStim). It competes for the same occupational therapy and stroke rehab budgets, although its products are mechanical/electrical orthoses rather than full robotic exoskeletons.

Broad incumbents

  • ReWalk Robotics: ReWalk Robotics is a publicly listed exoskeleton company focused primarily on lower-extremity personal and rehab devices (ReWalk Personal 6.0). It is a broad incumbent in the medical exoskeleton category and shares the same hospital and rehabilitation buyer universe as Harmonic Bionics.
  • Ekso Bionics: Ekso Bionics is a publicly listed wearable exoskeleton company best known for the EksoGT lower-extremity gait rehab device, with broader exposure in industrial and medical robotics. It is a broad incumbent in rehabilitation robotics with overlapping hospital buyers but a different anatomical focus.

Others

  • Bioness Medical: Bioness Medical is the strategic acquirer of Harmonic Bionics (June 2025) and now the parent company. It sells the L300 Go (FES) and other neuro-rehab products, so it is now the commercial platform through which Harmony SHR reaches customers, making it both a corporate parent and an adjacent rehab portfolio company.

Emerging players

  • BioXtreme: BioXtreme is a startup developing the BioXtreme upper-extremity robotic rehabilitation system for shoulder and arm therapy in neurological patients. It is an emerging player with partial overlap in product category and target use case (post-stroke upper-limb rehab), although it remains at an earlier commercialization stage.
  • Aretech (ZeroG): Aretech makes the ZeroG bodyweight-support and gait rehab system for neurological and orthopedic rehabilitation. It is an emerging player with partial overlap in the rehab robotics category, sharing the same inpatient rehab hospital buyers but focused on lower-extremity and balance therapy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Harmonic Bionics social profiles

Digital presence

Harmonic Bionics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Harmonic Bionics leadership team

Management profile

Number of profiles

Profiles5 records

Harmonic Bionics funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Harmonic Bionics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Harmonic Bionics

What does Harmonic Bionics do?

Harmonic Bionics develops and sells the Harmony SHR, a bilateral upper extremity robotic rehabilitation exoskeleton used by physical and occupational therapists to treat patients recovering from stroke, spinal cord injury, traumatic brain injury, and other neurological or musculoskeletal movement impairments. The system combines a biomechanically matched shoulder design (mimicking scapulohumeral rhythm) with bilateral sync mirror therapy, motorized sizing, and integrated motion/effort sensors to deliver objective, data-driven therapy. The company also offers EsmaCAT, a standalone high-speed mechatronics and software platform for robotic systems.

Is Harmonic Bionics a public or private company?

Harmonic Bionics is a private company. It is classified as venture growth investor backed and is currently acquired.

When was Harmonic Bionics founded?

Harmonic Bionics was founded in 2016. It employs 1 to 10 people.

Where is Harmonic Bionics based?

Harmonic Bionics is headquartered in Austin, United States, in the North America region.

How does Harmonic Bionics make money?

Two revenue lines are on record. Harmony SHR Hardware Sales are the primary driver. The others are professional Services (Training & Support).

Who are Harmonic Bionics's main competitors?

Direct peers on record are Tyromotion, Myomo, Hocoma (DIH Medical), Fourier Intelligence and Saebo. Broad incumbents are ReWalk Robotics and Ekso Bionics. Bioness Medical is listed as an others. Emerging players are BioXtreme and Aretech (ZeroG).

Does Harmonic Bionics have an API?

No public API is recorded for Harmonic Bionics.

What industry is Harmonic Bionics in?

Harmonic Bionics's product category is Rehabilitation Robotics. Its primary akta.pro industry code is HDAAAIAC, Healthcare & Assistive Robotics, with a secondary code of HLAHAMAG, Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices). Its NAICS code is 334510 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comGlobal Factors Influencing the Rapid Development of the Physiotherapy Equipment MarketA market report by The Business Research Company projects the global physiotherapy equipment market to reach $29.29 billion by 2030, growing at a 7.0% compound annual growth rate, driven by remote physiotherapy adoption, wearable rehabilitation devices, chronic pain prevalence, and digital therapy platforms. In June 2025, Bioness Medical, a US-based neurorehabilitation company, acquired Harmonic Bionics' assets and business to expand its upper-extremity robotic rehabilitation portfolio. Additionally, in November 2023, Chinese firm Syrebo launched two rehabilitation robots utilizing brain-computer interface and sensor-driven technologies.openPR.comExoskeleton Rehabilitation Market Overview: Major Segments, Strategic Developments, and Leading CompaniesThe exoskeleton rehabilitation market is projected to grow to $2.91 billion by 2030 with a compound annual growth rate of 17.4%, driven by technological advancements, AI-guided therapy integration, and increasing demand for mobility solutions. In June 2025, Bioness Medical Inc. acquired Harmonic Bionics Inc. to strengthen its portfolio in rehabilitation robotics and upper-extremity exoskeleton technology, with terms undisclosed. Lifeward Ltd., an Israeli medical device company, launched the ReWalk 7 Personal Exoskeleton in April 2025, a wearable robotic device enabling individuals with paraplegia to stand, walk, and climb stairs.openPR.comSegmentation, Major Trends, and Competitive Overview of the Exoskeleton Rehabilitation MarketThe Business Research Company published a market analysis projecting the global exoskeleton rehabilitation market to reach $2.48 billion by 2029, driven by technological advancements and increased healthcare funding. Key industry developments include Bioness Medical's acquisition of Harmonic Bionics in June 2025 and Lifeward Ltd.'s launch of the ReWalk 7 Personal Exoskeleton in April 2025.TracxnTop Companies in Exoskeletons (Oct, 2025)The article presents a ranked list of top exoskeleton startups as of October 2025, highlighting companies such as Ekso Bionics, Lifeward, Wandercraft, and Harmonic Bionics. It details their founding years, funding rounds, locations, and specific therapeutic applications for rehabilitation and mobility assistance.BioSpaceBioness Medical Announces Acquisition of the Assets and Business of Harmonic BionicsBioness Medical announced the acquisition of assets and business from Harmonic Bionics, expanding its neuro-rehabilitation product portfolio with a bilateral upper extremity robotic exoskeleton. This strategic move aims to complement Bioness's existing Vector Gait & Safety System and BITS technology once regulatory clearance is obtained from the FDA. The transaction marks Bioness's first acquisition since becoming an independent company in late 2024.PR NewswireBioness Medical Announces Acquisition of the Assets and Business of Harmonic BionicsBioness Medical announced the acquisition of assets and business from Harmonic Bionics to expand its neuro-rehabilitation robotics portfolio. The acquired bilateral upper extremity robotic exoskeleton is expected to complement Bioness's existing Vector Gait & Safety System once FDA clearance is obtained. This marks Bioness's first acquisition since becoming an independent organization in December 2024.MaadvisorLatest Market NewsBioness Medical has announced the acquisition of the assets and business of Harmonic Bionics, a robotics company based in Austin, Texas. This strategic move expands Bioness's portfolio into upper extremity neuro-rehabilitation with a robotic exoskeleton system that is pending FDA regulatory clearance. The transaction marks Bioness's first acquisition since becoming an independent entity in late 2024.FundzBioness Medical acquires Harmonic BionicsBioness Medical has acquired the assets and business of Harmonic Bionics to enhance its neuro-rehabilitation offerings, specifically targeting upper extremity mobility for patients with neurological deficits. This transaction marks Bioness's first acquisition since becoming an independent entity earlier in 2025.openPR.comRehabilitation Equipment Market Detailed Industry Analysis and Key Players Like Chinesport S.p.A, Invacare Corporation, Medline Industries LP.DataM Intelligence published a market research report on the global rehabilitation equipment market, covering segments, key players, and a forecast period of 2024-2031. The report highlights Harmonic Bionics' FDA registration of its Harmony SHR exoskeleton in April 2023. It also notes demand for customized solutions is driving growth.PR NewswireFirst International Harmony SHR® Robotic Rehabilitation System Installed at Prestigious Chinese University of Hong Kong Medical CentreHarmonic Bionics has installed the first Harmony SHR® bilateral upper extremity exoskeleton in Hong Kong at the Chinese University of Hong Kong (CUHK) Medical Centre, marking the company's first international placement through distributor Healthlink Holdings. The robotic rehabilitation system is designed to mimic the shoulder joint and enable natural arm range of motion for patients recovering from neurological or musculoskeletal impairments. The company views this as a strategic expansion into the Asian market, with CEO Mark Hunter calling it "a major milestone" for growth in the region.